| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |